AI Science Tracker
EN

Automated fat measurements associate with prostate therapy survival

University Hospital Münster; University of Münster; West German Cancer Centre · 28 Jun 2025 · medicine

Discovery

Automated fat measurements associate with prostate therapy survival

Source check: Source checked. Not independent scientific confirmation.

Finding: Deep-learning body segmentation measured fat compartments on routine PET/CT in 86 men receiving PSMA radioligand therapy. A higher intramuscular-fat proportion was associated with shorter overall survival, with volumetric measurements adding information beyond a single lumbar slice in the same cohort. This retrospective association does not establish a causal effect of fat, independent prediction or improved treatment selection.

Technology: Body and Organ Analysis; deep-learning CT segmentation

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The pretrained BOA segmentation framework delineates body compartments to derive volumetric fat fractions for clinical survival-association analysis.
Test and result
Clinical overall-survival associations of automated three-dimensional and single-slice fat measurements, with multivariable analysis in 86 treated patients.
Limitation / still unknown
Independent validation and clinical decision benefit remain unestablished; selection, limited sample size and model fitting/evaluation in the same cohort can produce optimistic estimates.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12660389/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.